Related Experiment Videos
Percutaneous treatment of iliac aneurysms and pseudoaneurysms with Cragg Endopro System 1 stent-grafts
D Gasparini1, A Lovaria, S Saccheri
1Institute of Radiology, Division of Vascular and Interventional Radiology, Azienda Ospedaliera S. Maria della Misericordia, Piazza S. Maria M, I-33100 Udine, Italy.
Insights
The Cragg Endopro System 1 stent-graft offers a safe and effective method for treating iliac artery aneurysms, demonstrating high success rates in short-term follow-up studies.
Area of Science:
- Vascular Surgery
- Interventional Radiology
Background:
- Iliac artery aneurysms pose significant risks.
- Endovascular repair offers a minimally invasive alternative to open surgery.
Purpose of the Study:
- To assess the feasibility and short-term outcomes of treating iliac aneurysms using the Cragg Endopro System 1 stent-graft.
Main Methods:
- Percutaneous implantation of 10 Cragg Endopro System 1 stent-grafts in 9 lesions (2 pseudoaneurysms, 7 atherosclerotic aneurysms) across 8 patients.
- Post-procedure anticoagulation with heparin followed by antiplatelet therapy.
- Follow-up included Doppler ultrasound at 2 days and 3 months, with angiography/angio-CT up to 12 months for some patients.
Main Results:
- Achieved a 100% initial clinical success rate.
- Reported two minor complications, including one device deployment failure requiring a second graft.
- All prostheses remained patent at 3-12 months, with one instance of minimal perigraft leak (12.5%).
Conclusions:
- Percutaneous stent-grafting with the Cragg Endopro System 1 is a safe and effective treatment for iliac artery aneurysms.
Purpose:
To evaluate the feasibility and short-term follow-up results of treating iliac aneurysms by the Cragg Endopro System 1 stent-graft.
Methods:
Nine lesions (two pseudoaneurysms and seven atherosclerotic aneurysms) were treated in eight patients by percutaneous implantation of a total of 10 stent-grafts. The procedure was followed by anticoagulation with heparin for 6 days, then antiplatelet therapy. Follow-up was by color Doppler ultrasound scan at 2 days and 3 months after the procedure for all patients, and by venous digital subtraction angiography and/or angio-CT up to 12 months later for four patients.
Results:
Initial clinical success rate was 100% and there were two minor complications. In one case the delivery system was faulty resulting in failure to deploy the stent-graft. An additional device had to be used. At 3-12 months all prostheses were patent but one patient (12.5%) had a minimal pergraft leak.
Conclusion:
Percutaneous stent-grafting with this device is a safe and efficacious treatment of iliac artery aneurysms.